Prelude Therapeutics participates in Chardan Healthcare Conference

PRLD•2026-10-16

Prelude Therapeutics will participate in the Chardan Healthcare Conference in New York City on October 20, 2026. Chief Scientific Officer Peggy Scherle and Chief Financial Officer Bryant Lim will join a fireside chat at 2 p.m. ET.

Prelude Therapeutics participates in Chardan Healthcare Conference

1. Conference participation

Related News

Polar Power holds annual shareholder meeting

US solicits exchange of up to 17 million barrels of oil from strategic reserve

Beta Bionics Chief Commercial Officer Mark Hopman sells common shares worth $13,446.25

Site Centers plans voluntary NYSE delisting before December 4, 2026

LexinFintech falls short of Nasdaq minimum bid price requirement